Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 8, 2013, Pages 1634-1637

  Jiang, Baoming ^a   Wang, Yuhuan ^a   Glass, Roger I ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CDC 9; Heat inactivation; Heterotypic protection; IRV; Rotavirus

Indexed keywords

ALUMINUM PHOSPHATE; IMMUNOGLOBULIN G; INACTIVATED VACCINE; PLACEBO; ROTAVIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; DRUG COST; DRUG EFFICACY; GNOTOBIOTICS; GUINEA PIG; HETEROTYPIC IMMUNITY; IMMUNITY; NONHUMAN; NOTE; PIGLET; ROTAVIRUS INFECTION; VACCINATION; VIRUS INACTIVATION; VIRUS NEUTRALIZATION;

CDC-9; HEAT INACTIVATION; HETEROTYPIC PROTECTION; IRV; ROTAVIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS PROTECTION; CROSS REACTIONS; GUINEA PIGS; HUMANS; INJECTIONS, INTRAMUSCULAR; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SWINE; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 84883033349     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24958     Document Type: Note

References (18)

1. Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30:S30-4; PMID:21183838; http://dx.doi.org/10.1097/INF.0b013e3181ffe3eb
2. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30:S6-10; PMID:21048524; http://dx.doi.org/10.1097/INF. 0b013e3181fefa05
3. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98; PMID:20107214; http://dx.doi.org/10.1056/NEJMoa0904797
4. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23; PMID:20692031; http://dx.doi.org/10.1016/S0140-6736(10)60755-6
5. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pen-tavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14; PMID:20692030; http://dx.doi.org/10.1016/S0140-6736(10)60889-6
6. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009; 200:S39-48; PMID:19817613; http://dx.doi.org/10.1086/605035
7. Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364:2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952
8. Buttery J P, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, et al.; PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29:3061-6; PMID:21316503; http://dx.doi.org/10. 1016/j.vaccine.2011.01.088
9. Payne DC, Edwards KM, Bowen MD, Keckley E, Peters J, Esona MD, et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics 2010; 125:e438-41; PMID:20100758; http://dx.doi.org/10.1542/peds.2009-1901
10. Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med 2010; 362:314-9; PMID:20107217; http://dx.doi.org/10.1056/ NEJMoa0904485
11. Jiang B, Gentsch JR, Glass RI. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine 2008; 26:6754-8; PMID:18951937; http://dx.doi.org/10.1016/j.vaccine.2008.10.008
12. Esona MD, Foytich K, Wang Y, Shin G, Wei G, Gentsch JR, et al. Molecular characterization of human rotavirus vaccine strain CDC-9 during sequential passages in Vero cells. Hum Vaccin 2010; 6:247-53; PMID:20009519; http://dx.doi.org/10.4161/hv.6.3.10409
13. Offit PA, Dudzik KI. Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge. J Clin Microbiol 1989; 27:885-8; PMID:2545743
14. Jiang B, Wang Y, Saluzzo JF, Bargeron K, Frachette MJ, Glass RI. Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum Vaccin 2008; 4:143-7; PMID:18382129; http://dx.doi.org/10.4161/hv.4.2.5263
15. Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine 2010; 28:5432-6; PMID:20558244; http://dx.doi.org/10.1016/j.vaccine.2010.06.006
16. Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022-8; PMID:8793926; http://dx.doi.org/10.1056/NEJM199610033351404
17. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med 1983; 309:72-6; PMID:6304516; http://dx.doi.org/10.1056/ NEJM198307143090203
18. Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis 2012; 12:213-20; PMID:22974466; http://dx.doi.org/10.1186/1471- 2334-12-213